Trial Profile

Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration

Status: Discontinued

Phase of Trial: Phase II

Latest Information Update: 24 Apr 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Brimonidine (Primary)
Indications Dry age-related macular degeneration
Focus Therapeutic Use
Acronyms BEACON
Sponsors Allergan

Most Recent Events

29 Aug 2018 Status changed from active, no longer recruiting to discontinued.
13 Apr 2018 This trial was Completed in Germany (End date: 2018-03-30), according to European Clinical Trials Database.
23 Feb 2018 This trial was Discontinued in Italy, according to European Clinical Trials Database.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com